NCT06680778 Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch
| NCT ID | NCT06680778 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 175 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 175 participants in total. It began in 2025-07-01 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this single center prospective observational study is to determine the effect of chemotherapy on (the change in) vital parameters. The main question it aims to answer are: Can changes in vital parameters be measured by using a Fitbit in patients with cancer while undergoing chemotherapy. Participants will be asked to wear a Fitbit for the first two cycles of chemotherapy to evaluate the changes in vital parameters.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years; * Diagnosis of stomach or esophageal cancer with an indication of starting chemotherapy * Knowledge how to handle a Fitbit * Mastery of Dutch language * Able and willing to give written informed consent Exclusion Criteria: * Cognitive disorders or severe emotional instability * Already participating in an exercise trial
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06680778 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06680778 currently recruiting?
Yes, NCT06680778 is actively recruiting participants. Contact the research team at j.denduijn@erasmusmc.nl for enrollment information.
Where is the NCT06680778 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands.
Who is sponsoring the NCT06680778 clinical trial?
NCT06680778 is sponsored by Erasmus Medical Center. The trial plans to enroll 175 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.